Skip to main content

Table 2 Baseline demographic characteristics after propensity score matching

From: Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up

VariablePitavastatin 1 mg (n = 251)Pitavastatin 4 mg (n = 251)p-value
Age (years)63.3 ± 12.262.6 ± 11.90.54
Male sex177 (70.5%)185 (73.7%)0.49
Body mass index (kg/m2)24.4 ± 3.024.6 ± 3.00.66
Diagnosis0.88
 Unstable angina184 (73.3%)181 (72.1%) 
 Non-ST elevation MI37 (14.7%)41 (16.3%) 
 ST elevation MI30 (12.0%)29 (11.6%) 
Risk factors
 Hypertension142 (56.6%)144 (57.4%)0.93
 Smoking status0.94
  Current smoker64 (25.5%)65 (25.9%) 
  Ex-smoker46 (18.3%)43 (17.1%) 
  Never smoker141 (56.2%)143 (57.0%) 
 Alcoholics46 (18.3%)44 (17.5%)0.91
 Prior stroke0 (0.0%)0 (0.0%)
Medication on admission
 Aspirin251 (100.0%)251 (100.0%)
 Clopidogrel215 (85.7%)204 (81.3%)0.23
 Ticagrelor40 (15.9%)48 (19.1%)0.41
 Prasugrel10 (4.0%)20 (8.0%)0.09
 ACE inhibitor41 (16.3%)49 (19.5%)0.42
 ARB82 (32.7%)78 (31.1%)0.77
 β-blocker117 (46.6%)118 (47.0%)0.99
 CCB86 (34.3%)84 (33.5%)0.93
 Diuretics49 (19.5%)44 (17.5%)0.65
Laboratory findings
 Total cholesterol (mg/dL)177.9 ± 41.4180.8 ± 46.60.46
 Triglyceride (mg/dL)145.7 ± 109.7162.6 ± 182.60.21
 HDL cholesterol (mg/dL)43.4 ± 10.642.9 ± 9.90.60
 LDL cholesterol (mg/dL)122.9 ± 34.2123.4 ± 34.20.88
 Creatinine (mg/dL)1.1 ± 1.50.9 ± 0.20.08
 Uric acid (mg/dL)5.6 ± 1.55.8 ± 1.60.23
 hsCRP (mg/L)5.6 ± 11.86.7 ± 15.90.43
 Fasting glucose (mmol/L)115.4 ± 29.3114.9 ± 26.30.85
 HbA1c (%)5.8 ± 0.45.8 ± 0.30.36
  1. Values are presented as mean ± standard deviation or n (%)
  2. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, CCB calcium channel blocker, HbA1c hemoglobin A1c, HDL high-density lipoprotein, hsCRP high sensitivity C-reactive protein, LDL low-density lipoprotein, MI myocardial infarction